Q1 2023 Excelsior Newsletter

Drug Trends to Watch, Actions to Consider by Robert Kordella, RPh, MBASenior Vice President and Chief Clinical Officer DIABETES Rising prescription costs related to the

Read More »

ICER Update 10.04.22

 Hello everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. ICER released a Final Evidence Report assessing the comparative clinical effectiveness and value

Read More »

Q3 2022 Excelsior Newsletter

Excelsior’s Opinion on So-Called “Vision Enhancement Products” by Robert Kordella, RPh, MBA, Chief Clinical Officer Three products have come to market recently that are being

Read More »